6
DVLA0212.TXT

DVLA
Darya-Varia Laboratoria Tbk
Af          :
Sector Code : 53
Sector Name : PHARMACEUTICALS

(In thousand rupiah except Par Value, Closing Price and Ratios)

Financial Statement Date    : 31-Dec-2002
Fiscal Year Ends            : Dec
Months Covered in Income St : 12

Summary of Balance Sheet
  Receivables               :      79,720,304.00
  Inventories               :      38,742,870.00
  Current Assets            :     178,697,369.00
  Fixed Assets              :      98,304,651.00
  Other Asstes              :          37,003.00
  Total Assets              :     322,921,805.00
  Current Liabilities       :      81,174,081.00
  Longterm Liabiities       :      14,662,450.00
  Total Liabilities         :      95,836,531.00
  Authorized                :         560,000.00
  Paid-up Capital           :     280,000,000.00
  Par Value                 :                500
  Paid-up Capital Shares    :         560,000.00
  Retained Earnings         :    -131,047,614.00
  Total Equity              :     227,085,274.00
  Minority Interest         :               0.00

Summary of Income Statement
  Total Sales               :     549,019,797.00
  Cost of Good Sold         :     281,233,949.00
  Gross Profit              :     267,785,848.00
  Operating Profit          :      70,562,577.00
  Other Income              :      28,881,471.00
  Eearning Before Tax       :      99,444,048.00
  Tax                       :      35,913,281.00
  Net Income                :      63,530,767.00
  Closing Price             :             460.00

Per Share Data (Rp)
  Eps                       :             113.45
  Book Value                :             405.51

Financial Ratios
  Debt Equity Ratio (X)     :                .42
  Roa (%)                   :              19.67
  Roe (%)                   :              27.98
  Npm (%)                   :              11.57
  Opm (%)                   :              12.85

Cash Flow
  CF from Operating Activities                        :      61,498,763.00
  CF from Investing Activities                        :      43,368,660.00
  CF from Financing Activities                        :     -71,600,133.00
  Net Increase in Cash & Cash Equivalent              :      33,267,290.00
  Cash & Cash Equivalent at The Beginning of The Year :      18,595,415.00
  Cash & Cash Equivalent at The End of The Year       :      51,739,136.00

 
 
 
